Ollivier Hélène, Pichavant-Rafini Karine, Puill-Stephan Eneour, Calvès Patrick, Nonnotte Liliane, Nonnotte Guy
Unité de Physiologie Comparée et Intégrative, U.F.R. Sciences et Techniques, 6 Avenue Le Gorgeu CS 93837, 29238 Brest, Cedex 3, France.
Biol Cell. 2006 Jul;98(7):427-37. doi: 10.1042/BC20050077.
ATP is released from many cell types exposed to hypo-osmotic shock and is involved in RVD (regulatory volume decrease). Purinergic signalling events have been extensively investigated in mammals, but not in marine teleosteans.
The effect of hypo-osmotic shock on ATP release was examined in isolated hepatocytes from turbot (Scophthalmus maximus), a marine flatfish. Hypo-osmotic stress (240 mOsm x kg(-1)) induced a significant increase in ATP efflux, and was inhibited by a potential CFTR (cystic fibrosis transmembrane conductance regulator) inhibitor, glibenclamide, but not by the MDR1 (multidrug resistance 1) P-glycoprotein inhibitor, verapamil. ATP efflux could be a cAMP-dependent process, as IBMX (isobutylmethylxanthine) and forskolin triggered the process under iso-osmotic conditions. Protein kinases, including protein kinase C, could also be involved, as staurosporine and chelerythrine inhibited the mechanism. Calcium could contribute to ATP efflux as ionomycin, a calcium ionophore, elicited a rapid release under iso-osmotic conditions, and chelation using EGTA abolished ATP release under hypo-osmotic conditions. RVD was partially abolished by apyrase, an ATP scavenger, and suramin, a purinoceptor antagonist. Moreover, hypo-osmotic shock induced a rise in intracellular calcium which could be involved in RVD. Since extracellular ATP triggered an increase in cellular free-calcium content under iso-osmotic conditions, our results could indicate that hypo-osmotic-induced ATP efflux contributes to RVD in turbot hepatocytes by stimulating purinergic receptors, which may lead to activation of a calcium signalling pathway.
These data provide the first evidence of volume-sensitive ATP signalling for volume maintenance in a marine teleost fish cell type.
三磷酸腺苷(ATP)可从许多遭受低渗休克的细胞类型中释放出来,并参与调节性容积减小(RVD)过程。嘌呤能信号转导事件在哺乳动物中已得到广泛研究,但在海洋硬骨鱼类中尚未有相关研究。
研究了低渗休克对大菱鲆(一种海洋比目鱼)离体肝细胞中ATP释放的影响。低渗应激(240 mOsm×kg⁻¹)导致ATP外排显著增加,且受到潜在的囊性纤维化跨膜传导调节因子(CFTR)抑制剂格列本脲的抑制,但不受多药耐药蛋白1(MDR1)P-糖蛋白抑制剂维拉帕米的抑制。ATP外排可能是一个环磷酸腺苷(cAMP)依赖性过程,因为异丁基甲基黄嘌呤(IBMX)和福斯高林在等渗条件下可触发该过程。包括蛋白激酶C在内的蛋白激酶也可能参与其中,因为星形孢菌素和白屈菜红碱可抑制该机制。钙可能有助于ATP外排,因为钙离子载体离子霉素在等渗条件下可引发快速释放,而使用乙二醇双四乙酸(EGTA)螯合可消除低渗条件下的ATP释放。ATP清除剂Apyrase和嘌呤受体拮抗剂苏拉明可部分消除RVD。此外,低渗休克导致细胞内钙升高,这可能与RVD有关。由于细胞外ATP在等渗条件下可引发细胞游离钙含量增加,我们的结果可能表明,低渗诱导的ATP外排通过刺激嘌呤能受体促进大菱鲆肝细胞中的RVD,这可能导致钙信号通路的激活。
这些数据首次证明了在海洋硬骨鱼类细胞类型中存在对容积敏感的ATP信号以维持容积。